Differential expression of platelet-activating factor acetylhydrolase in lung macrophages

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 6, 2009, Pages

  Howard, Katherine M ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

Acute lung injury; Endotoxin; Inflammation; Lipid mediator; Lipopolysaccharide; Lipoprotein associated phospholipase A 2

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; RIBONUCLEASE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; GLYCOSYLATION; GRANULOCYTE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; LUNG INTERSTITIUM; LUNG PARENCHYMA; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSIDE HYDROLASES; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS;

EID: 71949085277     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00022.2009     Document Type: Article

References (50)

1. Ambrosio G, Oriente A, Napoli C, Palumbo G, Chiariello P, Marone G, Condorelli M, Chiariello M, Triggiani M. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J Clin Invest 93: 2408-2416, 1994. (Pubitemid 24177153)
2. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM. The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 157: 1332-1347, 1998. (Pubitemid 28225208)
3. Asano K, Okamoto S, Fukunaga K, Shiomi T, Mori T, Iwata M, Ikeda Y, Yamaguchi K. Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. Biochem Biophys Res Commun 261: 511-514, 1999. (Pubitemid 29392507)
4. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.[see comment]. Arch Intern Med 165: 2479-2484, 2005. (Pubitemid 41720009)
5. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Heiss G, Sharrett AR. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.[see comment]. Circulation 109: 837-842, 2004. (Pubitemid 38252734)
6. Beelen RHJ, Estermans IL, Dopp EA, Dijkstra CD. Monoclonal antibodies ED1, ED2, and ED3 against rat macrophages: expression of recognized antigens in different stages of differentiation. Trans Proced XIX: 3166-3170, 1987.
7. Brigham KL, Begley CJ, Bernard GR, Hutchison AA, Loyd JE, Lucht WD, Meyrick B, Newman JH, Niedermeyer ME, Ogletree ML. Septicemia and lung injury. Clin Lab Med 3: 719-744, 1983.
8. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 133: 913-927, 1986.
9. Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 273: 4012-4020, 1998. (Pubitemid 28103265)
10. Caplan MS, Sun XM, Hseuh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 116: 960-964, 1990. (Pubitemid 20201711)
11. Chang SW, Feddersen CO, Henson PM, Voelkel NF. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxintreated rats. J Clin Invest 79: 1498-1509, 1987.
12. Chen CR, Voelkel NF, Chang SW. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids. Am J Respir Crit Care Med 149: 34-40, 1994. (Pubitemid 24978008)
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
14. Christman BW, Lefferts PL, King GA, Snapper JR. Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. J Appl Physiol 64: 2033-2041, 1988.
15. Claus RA, Russwurm S, Dohrn B, Bauer M, Losche W. Plasma platelet-activating factor acetylhydrolase activity in critically ill patients. Crit Care Med 33: 1416-1419, 2005. (Pubitemid 40827398)
16. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. Adv Exp Med Biol 186: 409-419, 1985.
17. Furukawa M, Lee EL, Johnston JM. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. Pediatr Res 34: 237-241, 1993. (Pubitemid 23207214)
18. Gandhi CR, Stephenson K, Olson MS. A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J 281: 485-492, 1992.
19. Gomes RN, Bozza FA, Amancio RT, Japiassu AM, Vianna RCS, Larangeira AP, Gouvea JM, Bastos MS, Zimmerman GA, Stafforini DM, Prescott SM, Bozza PT, Castro-Faria-Neto HC. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 26: 41-49, 2006.
20. Grissom CK, Orme JF, Richer LD, McIntyre TM, Zimmerman GA, Elstad MR. Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome. Crit Care Med 31: 770-775, 2003.
21. Howard KM, Miller JE, Miwa M, Olson MS. Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 272: 27543-27548, 1997. (Pubitemid 27473544)
22. Howard KM, Olson MS. The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. J Biol Chem 275: 19891-19896, 2000. (Pubitemid 30441593)
23. Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, Sunaga S, Cao W, Kume K, Fukuchi Y, Ikuta K, Miyazaki J, Kumada M, Shimizu T. Impaired anaphylatic respinses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 187: 1779-1788, 1998. (Pubitemid 28262442)
24. Ishii S, Nagase T, Tashiro F, Ikuta K, Sato S, Waga I, Kume K, Miyazaki J, Shimizu T. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 16: 133-142, 1997. (Pubitemid 27032856)
25. Knook DL, Sleyster EC. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 99: 444-449, 1976.
26. Koenig W, Twardella D, Brenner H, Rothenbacher D. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol 26: 1586-1593, 2006. (Pubitemid 44288987)
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
28. MacRitchie AN, Gardner AA, Prescott SM, Stafforini DM. Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation. FASEB J 21: 1164-1176, 2007.
29. Meade CJ, Birke F, Metcalfe S, Watson C, Jamieson N, Neild G. Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation. J Lipid Mediat Cell Signal 9: 205-215, 1994. (Pubitemid 24170583)
30. Mengozzi M, Ghezzi P. Cytokine down-regulation in endotoxin tolerance. Eur Cytokine Netw 4: 89-98, 1993.
31. Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, Araki Y, Matsumoto M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest 82: 1983-1991, 1988. (Pubitemid 19054946)
32. Miyaura S, Eguchi H, Johnston JM. Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ Res 70: 341-347, 1992.
33. Nakamura M, Honda Z, Izumi T, Sakanaka C, Mutoh H, Minami M, Bito H, Seyama Y, Matsumoto T, Noma M. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 266: 20400-20405, 1991. (Pubitemid 21908472)
34. Nakos G, Pneumatikos J, Tsangaris I, Tellis C, Lekka M. Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Respir Crit Care Med 155: 945-951, 1997. (Pubitemid 27133407)
35. Oei HHS, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MMB, Witteman JCM. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation 111: 570-575, 2005. (Pubitemid 40216483)
36. Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group[see comment]. N Engl J Med 343: 1148-1155, 2000.
37. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419-445, 2000.
38. Reckless J, Tatalick LM, Grainger DJ. The pan-chemokine inhibitor NR58-3.143 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo. Immunology 103: 244-254, 2001. (Pubitemid 32521354)
39. Salluh JI, Pino AV, Silva AR, Gomes RN, Souza HS, Lapa e Silva JR, Jandre FC, Giannella-Neto A, Zimmerman GA, Stafforini DM, Prescott SM, Castro-Faria-Neto HC, Bozza PT, Bozza FA. Lung production of platelet-activating factor acetylhydrolase in oleic acid-induced acute lung injury. Prostaglandins Leukot Essent Fatty Acids 77: 1-8, 2007.
40. Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Takamatsu M. Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension. Prostaglandins 37: 673-682, 1989. (Pubitemid 19202653)
41. Snyder F, Blank ML, Lee TC. Metabolism of platelet activating factor in lung. Annals NY Acad Sci 629: 168-175, 1991.
42. Stafforini DM, Elstad MR, McIntyre TM, Zimmerman GA, Prescott SM. Human macrophages secret platelet-activating factor acetylhydrolase. J Biol Chem 265: 9682-9687, 1990. (Pubitemid 20194309)
43. Stafforini DM, Prescott SM, McIntyre TM. Human plasma platelet-activating factor acetylhydrolase. Purif Prop J Biol Chem 262: 4223-4230, 1987.
44. Tetta C, Bussolino F, Modena V, Montrucchio G, Segoloni G, Pescarmona G, Camussi G. Release of platelet-activating factor in systemic lupus erythematosus. Int Arch Allergy Appl Immunol 91: 244-256, 1990. (Pubitemid 20182314)
45. Tew DG, Southan C, Rice SQ, Lawrence MP, Li H, Boyd HF, Moores K, Gloger IS, Macphee CH. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler Thromb Vasc Biol 16: 591-599, 1996. (Pubitemid 126451259)
46. Tjoelker LW, Eberhardt C, Unger J, Trong HL, Zimmerman GA, McIntyre TM, Stafforini DM, Prescott SM, Gray PW. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem 270: 25481-25487, 1995.
47. Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Le Trong H, Cousens LS, Zimmerman GA. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase [see comments]. Nature 374: 549-553, 1995.
48. Triggiani M, De Marino V, Sofia M, Faraone S, Ambrosio G, Carratu L, Marone G. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. Am J Respir Crit Care Med 156: 94-100, 1997. (Pubitemid 27293172)
49. Tselepis AD, Karabina SAP, Stengel D, Piedagnel R, Chapman MJ, Ninio E. N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL. J Lipid Res 42: 1645-1654, 2001. (Pubitemid 33020097)
50. Wu X, Zimmerman GA, Prescott SM, Stafforini DM. The p38 MAPK pathway mediates transcriptional activation of the plasma platelet-activating factor acetylhydrolase gene in macrophages stimulated with lipopolysaccharide. J Biol Chem 279: 36158-36165, 2004. (Pubitemid 39100624)